132 related articles for article (PubMed ID: 8306496)
21. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones.
Arvieux J; Yssel H; Colomb MG
Immunology; 1988 Oct; 65(2):229-35. PubMed ID: 2973431
[TBL] [Abstract][Full Text] [Related]
22. Presentation of Candida albicans and purified protein derivative soluble antigens by Epstein-Barr virus-transformed human lymphoblastoid B-cell lines.
Reitnauer PJ; Brown LR; Hank JA; Sondel PM
Cell Immunol; 1986 Apr; 99(1):196-208. PubMed ID: 3019572
[TBL] [Abstract][Full Text] [Related]
23. Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of FcgammaRII.
Antoniou AN; Watts C
Eur J Immunol; 2002 Feb; 32(2):530-40. PubMed ID: 11828370
[TBL] [Abstract][Full Text] [Related]
24. Noncytotoxic human CD4+ T-cell clones presenting and simultaneously responding to an antigen die of apoptosis.
Bettens F; Frei E; Frutig K; Mauri D; Pichler WJ; Wyss-Coray T
Cell Immunol; 1995 Mar; 161(1):72-8. PubMed ID: 7532549
[TBL] [Abstract][Full Text] [Related]
25. Detection of HLA class II-dependent T helper antigen using antigen phage display.
Somasundaram R; Satyamoorthy K; Caputo L; Yssel H; Herlyn D
Clin Exp Immunol; 2004 Feb; 135(2):247-52. PubMed ID: 14738452
[TBL] [Abstract][Full Text] [Related]
26. Delineation of several DR-restricted tetanus toxin T cell epitopes.
Demotz S; Lanzavecchia A; Eisel U; Niemann H; Widmann C; Corradin G
J Immunol; 1989 Jan; 142(2):394-402. PubMed ID: 2463305
[TBL] [Abstract][Full Text] [Related]
27. Herpesvirus saimiri transformed T cells and peripheral blood mononuclear cells restimulate identical antigen-specific human T cell clones.
Daubenberger CA; Nickel B; Hübner B; Siegler U; Meinl E; Pluschke G
J Immunol Methods; 2001 Aug; 254(1-2):99-108. PubMed ID: 11406156
[TBL] [Abstract][Full Text] [Related]
28. Epitope repertoire of human CD4+ lines propagated with tetanus toxoid or with synthetic tetanus toxin sequences.
Raju R; Diethelm-Okita B; Okita D; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):79-88. PubMed ID: 8845057
[TBL] [Abstract][Full Text] [Related]
29. Endogenous antigen presentation by autoantigen-transfected Epstein-Barr virus-lymphoblastoid cells. I. Generation of human thyroid peroxidase-reactive T cells and their T cell receptor repertoire.
Martin A; Magnusson RP; Kendler DL; Concepcion E; Ben-Nun A; Davies TF
J Clin Invest; 1993 Apr; 91(4):1567-74. PubMed ID: 7682574
[TBL] [Abstract][Full Text] [Related]
30. Antigen processing and presentation by EBV-carrying cell lines: cell-phenotype dependence and influence of the EBV-encoded LMP1.
de Campos-Lima PO; Torsteinsdóttir S; Cuomo L; Klein G; Sulitzeanu D; Masucci MG
Int J Cancer; 1993 Mar; 53(5):856-62. PubMed ID: 8383631
[TBL] [Abstract][Full Text] [Related]
31. Mapping the major human T helper epitopes of tetanus toxin. The emerging picture.
Reece JC; Geysen HM; Rodda SJ
J Immunol; 1993 Dec; 151(11):6175-84. PubMed ID: 7504014
[TBL] [Abstract][Full Text] [Related]
32. Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.
Roosnek E; Lanzavecchia A
J Exp Med; 1991 Feb; 173(2):487-9. PubMed ID: 1703209
[TBL] [Abstract][Full Text] [Related]
33. Antigen presentation by human dermal fibroblasts: activation of resting T lymphocytes.
Umetsu DT; Katzen D; Jabara HH; Geha RS
J Immunol; 1986 Jan; 136(2):440-5. PubMed ID: 3484491
[TBL] [Abstract][Full Text] [Related]
34. Altered antigen-presentation in the induction of the in-vitro antigen-specific T helper cell function in patients with chronic granulomatous disease.
Heijnen CJ; van der Meer JW; Zegers BJ
Clin Exp Immunol; 1986 Oct; 66(1):111-7. PubMed ID: 2948743
[TBL] [Abstract][Full Text] [Related]
35. Major histocompatibility complex restriction of tetanus toxoid-specific human T lymphocyte clones.
Schmitt C; Cogné M; Agrapart M; Ballet JJ
Eur J Immunol; 1984 Dec; 14(12):1131-6. PubMed ID: 6083872
[TBL] [Abstract][Full Text] [Related]
36. Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease.
Alexander MA; Bennicelli J; Guerry D
J Immunol; 1989 Jun; 142(11):4070-8. PubMed ID: 2469732
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of MHC-antigen complex formation on antigen-presenting cells.
Roosnek E; Demotz S; Corradin G; Lanzavecchia A
J Immunol; 1988 Jun; 140(12):4079-82. PubMed ID: 2453565
[TBL] [Abstract][Full Text] [Related]
38. MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways.
Lee SP; Wallace LE; Mackett M; Arrand JR; Searle PF; Rowe M; Rickinson AB
Int Immunol; 1993 May; 5(5):451-60. PubMed ID: 8391306
[TBL] [Abstract][Full Text] [Related]
39. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
40. Study on the immunogenicity of human class-II-restricted T-cell epitopes: processing constraints, degenerate binding, and promiscuous recognition.
Panina-Bordignon P; Demotz S; Corradin G; Lanzavecchia A
Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():445-51. PubMed ID: 2484166
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
